EcoR1 Capital, LLC - Oct 13, 2023 Form 3 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
10%+ Owner
Signature
/s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC
Stock symbol
TNGX
Transactions as of
Oct 13, 2023
Transactions value $
$0
Form type
3
Date filed
10/16/2023, 03:42 PM
Previous filing
Jul 31, 2023
Next filing
Dec 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNGX Common Stock 13.3M Oct 13, 2023 See Notes 1 and 2 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim ownership of such securities except to the extent of their respective pecuniary interests therein.
F2 Qualified Fund directly holds 12,563,381 of the shares of Common Stock reported in this Form 3.